DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Erdosteine is an investigational drug.
There have been 4 clinical trials for Erdosteine. The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are Lung Diseases, Obstructive, Lung Diseases, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are Hull and East Yorkshire Hospitals NHS Trust, Galen limited, and Edmond Pharma.
Recent Clinical Trials for Erdosteine
|Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers||Daewoong Pharmaceutical Co. LTD.||Phase 1|
|The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)||Edmond Pharma||Phase 3|
|Phase 2 Study - Erdosteine in Patients With CB/COPD||Adams Respiratory Therapeutics||Phase 2|